tetano
Editor, Senior Moderator
Medicina (Kaunas)
. 2021 Nov 29;57(12):1306.
doi: 10.3390/medicina57121306.
Facts and Challenges about Asthma and COVID-19 among the Paediatric Population: A Systematic Literature Review
Emilia Moreno-Sánchez[SUP] 1 [/SUP], Estefanía Castillo-Viera[SUP] 2 [/SUP], Emilia Vélez-Moreno[SUP] 3 [/SUP], Francisco-Javier Gago-Valiente[SUP] 4 [/SUP]
Affiliations
Abstract
A systematic review of the literature was conducted to analyse the factors that affect the probability of the paediatric asthma population suffering from COVID-19 or SARS-CoV-2, such as asthma phenotypes, inhaled corticosteroids, and the effects of lockdown. This systematic review was based on PRISMA guidelines. A bibliographic search was conducted using BNE, BVS (LILAC), CSIC (IME, ISOC), IBECS, Scielo, Scopus, Medline, and PubMed, using the following search profile: (COVID-19 or 2019-NCOV or SARS-CoV-2 or COV-19) AND asthma AND (children or adolescents or youths or children or teenagers). The results were limited to those articles published between December 2019 and December 2020, selecting only articles published in Spanish, English and French that included the study population (children aged 0-18 years). Among the 1066 results of the bibliographic search and seven articles selected from a manual search, only 19 articles were found to fit our eligibility criteria. Most of the articles highlight the effects of lockdown on the paediatric asthma population, increased therapeutic compliance, and the role of inhaled corticosteroids and intrinsic factors such as ACE2 receptors as causes of the decreased prevalence of COVID-19 among the paediatric asthma population. This population has unique characteristics that serve as protective factors against COVID-19. The safety measures implemented during the lockdown period along with inhaled corticosteroid treatment also contributed to this protection.
Keywords: COVID-19; SARS-Cov-2; asthma; coronavirus; paediatric population; paediatrics.
. 2021 Nov 29;57(12):1306.
doi: 10.3390/medicina57121306.
Facts and Challenges about Asthma and COVID-19 among the Paediatric Population: A Systematic Literature Review
Emilia Moreno-Sánchez[SUP] 1 [/SUP], Estefanía Castillo-Viera[SUP] 2 [/SUP], Emilia Vélez-Moreno[SUP] 3 [/SUP], Francisco-Javier Gago-Valiente[SUP] 4 [/SUP]
Affiliations
- PMID: 34946251
- DOI: 10.3390/medicina57121306
Abstract
A systematic review of the literature was conducted to analyse the factors that affect the probability of the paediatric asthma population suffering from COVID-19 or SARS-CoV-2, such as asthma phenotypes, inhaled corticosteroids, and the effects of lockdown. This systematic review was based on PRISMA guidelines. A bibliographic search was conducted using BNE, BVS (LILAC), CSIC (IME, ISOC), IBECS, Scielo, Scopus, Medline, and PubMed, using the following search profile: (COVID-19 or 2019-NCOV or SARS-CoV-2 or COV-19) AND asthma AND (children or adolescents or youths or children or teenagers). The results were limited to those articles published between December 2019 and December 2020, selecting only articles published in Spanish, English and French that included the study population (children aged 0-18 years). Among the 1066 results of the bibliographic search and seven articles selected from a manual search, only 19 articles were found to fit our eligibility criteria. Most of the articles highlight the effects of lockdown on the paediatric asthma population, increased therapeutic compliance, and the role of inhaled corticosteroids and intrinsic factors such as ACE2 receptors as causes of the decreased prevalence of COVID-19 among the paediatric asthma population. This population has unique characteristics that serve as protective factors against COVID-19. The safety measures implemented during the lockdown period along with inhaled corticosteroid treatment also contributed to this protection.
Keywords: COVID-19; SARS-Cov-2; asthma; coronavirus; paediatric population; paediatrics.